Cambiar Investors’s Amedisys AMED Stock Holding History

Cambiar Investors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-89,982	Closed	-$6.62M	–	145
2023 Q1	$6.62M	Buy	89,982 +4,733	+6%	+$409K	0.29%	86
2022 Q4	$7.12M	Buy	85,249 +23,620	+38%	+$2.13M	0.32%	85
2022 Q3	$5.96M	Buy	61,629 +2,986	+5%	+$356K	0.3%	84
2022 Q2	$6.17M	Sell	58,643 -2,504	-4%	-$320K	0.27%	85
2022 Q1	$10.5M	Buy	61,147 +264	+0.4%	+$39.4K	0.4%	57
2021 Q4	$9.86M	Buy	+60,883	New	+$9.78M	0.34%	67

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Cambiar Investors's AMED Position: Q2 2023 in Review

Cambiar Investors sold out of Amedisys (AMED) in Q2 2023, closing a stake of 89,982 shares — an estimated $6.62M sold.

Cambiar Investors first reported a position in AMED in Q4 2021 and held it in 6 quarters. The position peaked at $10.5M in Q1 2022. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

Cambiar Investors reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
Cambiar Investors sold 89,982 Amedisys shares in Q2 2023, an estimated $6.62M.
Cambiar Investors first reported a position in Amedisys in Q4 2021 and held it in 6 quarters.
Cambiar Investors's Amedisys position peaked at $10.5M in Q1 2022.
301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Cambiar Investors's 13F filing for Q2 2023, filed 31 Jul 2023.